Nathalie Jolly

1.2k total citations
6 papers, 169 citations indexed

About

Nathalie Jolly is a scholar working on Infectious Diseases, Epidemiology and Endocrinology. According to data from OpenAlex, Nathalie Jolly has authored 6 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Epidemiology and 2 papers in Endocrinology. Recurrent topics in Nathalie Jolly's work include Viral gastroenteritis research and epidemiology (2 papers), Escherichia coli research studies (2 papers) and Sepsis Diagnosis and Treatment (1 paper). Nathalie Jolly is often cited by papers focused on Viral gastroenteritis research and epidemiology (2 papers), Escherichia coli research studies (2 papers) and Sepsis Diagnosis and Treatment (1 paper). Nathalie Jolly collaborates with scholars based in France, United Kingdom and French Guiana. Nathalie Jolly's co-authors include Christine Sadorge, Jean‐Baptiste Dufourcq, Nareth Chhor, Philippe Buchy, Jean‐Marc Reynes, Bernard Marcel Diop, Sivuth Ong, Laurent Dacheux, Dominique Rousset and C Rathat and has published in prestigious journals such as Clinical Infectious Diseases, Vaccine and Scandinavian Journal of Immunology.

In The Last Decade

Nathalie Jolly

6 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Jolly France 4 106 64 59 46 38 6 169
Agnes Theresia Soelih Estoepangestie Indonesia 5 88 0.8× 38 0.6× 35 0.6× 22 0.5× 68 1.8× 17 151
Bhagwat Gunale India 7 78 0.7× 32 0.5× 64 1.1× 27 0.6× 71 1.9× 12 178
I Vodopija Croatia 10 162 1.5× 48 0.8× 101 1.7× 62 1.3× 172 4.5× 31 293
Eric L. Marston United States 10 68 0.6× 63 1.0× 230 3.9× 13 0.3× 26 0.7× 10 347
Samar Freschi Barros Brazil 9 34 0.3× 146 2.3× 167 2.8× 9 0.2× 45 1.2× 18 313
Evelene Steward‐Clark United States 6 63 0.6× 21 0.3× 83 1.4× 9 0.2× 60 1.6× 11 233
Reinaldo E. Fernández United States 8 40 0.4× 10 0.2× 108 1.8× 57 1.2× 67 1.8× 20 222
Pranee Chomchey Thailand 9 245 2.3× 78 1.2× 84 1.4× 56 1.2× 169 4.4× 11 293
Palmira Ventosilla Peru 10 88 0.8× 80 1.3× 157 2.7× 6 0.1× 8 0.2× 19 306
Gadey Sampath India 9 213 2.0× 95 1.5× 135 2.3× 39 0.8× 135 3.6× 14 289

Countries citing papers authored by Nathalie Jolly

Since Specialization
Citations

This map shows the geographic impact of Nathalie Jolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Jolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Jolly more than expected).

Fields of papers citing papers by Nathalie Jolly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Jolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Jolly. The network helps show where Nathalie Jolly may publish in the future.

Co-authorship network of co-authors of Nathalie Jolly

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Jolly. A scholar is included among the top collaborators of Nathalie Jolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Jolly. Nathalie Jolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Gagneux‐Brunon, Amandine, Clémentine Schilte, Arnauld Garcin, et al.. (2021). Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic. Trials. 22(1). 373–373. 1 indexed citations
3.
Dacheux, Laurent, Jean‐Marc Reynes, Philippe Buchy, et al.. (2008). A Reliable Diagnosis of Human Rabies Based on Analysis of Skin Biopsy Specimens. Clinical Infectious Diseases. 47(11). 1410–1417. 114 indexed citations
4.
Sadorge, Christine, Anna Julienne Selbé Ndiaye, Rafaela Giemza, et al.. (2007). Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers. Vaccine. 26(7). 978–987. 13 indexed citations
5.
Bourreau, Eliane, Hervé Pascalis, Ghislaine Prévot, et al.. (2003). Increased Production of Interferon‐γ by Leishmania Homologue of the Mammalian Receptor for Activated C Kinase‐Reactive CD4+ T cells among Human Blood Mononuclear Cells: An Early Marker of Exposure to Leishmania?. Scandinavian Journal of Immunology. 58(2). 201–210. 11 indexed citations
6.
Ureta‐Vidal, Abel, Cristina Angelin‐Duclos, Patricia Tortevoye, et al.. (1999). Mother-to-child transmission of HTLV-I : implication of high antiviral antibody titer and high proviral load in carrier mothers.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(4). A53–A53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026